DENTSPLY SIRONA Inc (NASDAQ:XRAY) Stock Holdings Lifted by Manitou Investment Management Ltd.

Share on StockTwits

Manitou Investment Management Ltd. boosted its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 624,172 shares of the medical instruments supplier’s stock after purchasing an additional 4,388 shares during the period. DENTSPLY SIRONA comprises about 8.0% of Manitou Investment Management Ltd.’s investment portfolio, making the stock its 3rd biggest position. Manitou Investment Management Ltd.’s holdings in DENTSPLY SIRONA were worth $33,275,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in XRAY. Altshuler Shaham Ltd raised its stake in shares of DENTSPLY SIRONA by 209.8% in the second quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock worth $30,000 after buying an additional 342 shares during the period. Quest Capital Management Inc. ADV bought a new position in shares of DENTSPLY SIRONA in the third quarter worth about $30,000. Cornerstone Advisors Inc. raised its stake in shares of DENTSPLY SIRONA by 62.0% in the second quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 346 shares during the period. Van ECK Associates Corp bought a new position in shares of DENTSPLY SIRONA in the second quarter worth about $54,000. Finally, Arcadia Investment Management Corp MI bought a new position in shares of DENTSPLY SIRONA in the second quarter worth about $58,000. 93.46% of the stock is currently owned by institutional investors and hedge funds.

XRAY traded up $0.34 on Friday, hitting $57.42. 2,699,300 shares of the company’s stock traded hands, compared to its average volume of 1,735,074. The firm has a market cap of $12.31 billion, a price-to-earnings ratio of 28.57, a P/E/G ratio of 1.97 and a beta of 0.96. The company has a current ratio of 2.08, a quick ratio of 1.39 and a debt-to-equity ratio of 0.30. The company’s 50 day simple moving average is $53.88 and its 200-day simple moving average is $54.19. DENTSPLY SIRONA Inc has a one year low of $34.93 and a one year high of $60.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.07. The firm had revenue of $962.10 million during the quarter, compared to analysts’ expectations of $940.38 million. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The company’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.38 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc will post 2.39 EPS for the current fiscal year.

Several research analysts have recently commented on the company. Barclays raised their price objective on DENTSPLY SIRONA from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Friday. BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Saturday. ValuEngine downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd. Stifel Nicolaus raised their price objective on DENTSPLY SIRONA from $61.00 to $63.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Evercore ISI began coverage on DENTSPLY SIRONA in a research note on Friday, July 26th. They set an “in-line” rating on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $57.37.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: Leveraged Buyout (LBO)

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.